Top Market Research Companies in Australia Specializing in Healthcare
Compare top healthcare market research companies in Australia for 2026 to find verified medical panels and strategic insights for your pharmaceutical brand.
Quick answer
For large-scale, international healthcare studies, Global Vox Populi; for localized brand strategy and creative testing, Kantar Australia; for physician recruitment and fieldwork, M3 Global Research; and for behavioral-led healthcare consulting, Hummingbird Insight are the primary choices for Australian decision-makers.
Finding the right healthcare market research companies in Australia requires balancing deep clinical knowledge with the ability to work through local regulatory and cultural nuances. Insights directors and brand managers must choose between large, multi-disciplinary agencies that offer broad strategic support and specialized firms that provide rapid, high-quality access to niche medical audiences.
This assessment examines the capabilities of various providers to help you determine which firm aligns with your specific therapeutic area and research objectives. Whether you are managing a pharmaceutical launch, assessing patient journey experiences, or tracking physician attitudes, selecting the correct partner is fundamental to the accuracy and actionability of your data. This guide provides a framework to evaluate these options in the context of the 2026 market.
Top Market Research Companies in Australia Specializing in Healthcare: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | IQVIA Australia | End-to-end clinical and commercial data analytics | 88.0 |
| 2 | Global Vox Populi | Large-scale international healthcare professional research | 85.5 |
| 3 | Ipsos Australia | Public health and patient experience tracking | 82.0 |
| 4 | M3 Global Research | Rapid physician and specialist recruitment | 80.0 |
| 5 | Kantar Australia | Brand growth and creative effectiveness testing | 78.5 |
| 6 | Sago | Agile quantitative and qualitative data collection | 76.5 |
| 7 | Ruby Cha Cha | Deep qualitative insights and ethnographic research | 71.0 |
| 8 | Hummingbird Insight | Behavioral science-led healthcare strategy | 70.5 |
| 9 | Lonergan Research | Tailored B2B and B2C research strategy | 68.0 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| IQVIA Australia | Physicians, pharmacists, wholesalers, and clinical trial sites | Internal data validation and site intelligence protocols | Not stated on pages reviewed | Not published | Not published | Not published |
| Global Vox Populi | Physicians, specialists, nurses, patients, and payers | Rolling re-validation against license and registry records | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Project quote | 23,864 healthcare professionals; 772,736 patient profiles; 47,451 nurses and allied health professionals (in Australia; Global Vox Populi panel records, Oct 2026) | Not published |
| Ipsos Australia | Patients, doctors, and the general public | Scientific methodology and data validation protocols | Not stated on pages reviewed | Not published | Not published | Not published |
| M3 Global Research | Physicians, specialists, nurses, and pharmacists | Verification of physician credentials and professional status | Not stated on pages reviewed | Not published | Over 2 million professionals globally (m3globalresearch.com, Oct 2026) | Not published |
| Kantar Australia | Consumers and brand decision-makers | Validated methodologies and expert interpretation | Not stated on pages reviewed | Not published | Not published | Not published |
| Sago | Diverse patients, consumers, and medical professionals | SagoVerify data quality processes | Not stated on pages reviewed | Not published | 176 million respondents globally (sago.com, Oct 2026) | Not published |
| Ruby Cha Cha | Patients, practitioners, and consumers | Consultative oversight and rigorous qualitative design | Not stated on pages reviewed | Not published | Not published | Not published |
| Hummingbird Insight | Healthcare professionals and patients | Expert research design and analysis | Not stated on pages reviewed | Not published | Not published | Not published |
| Lonergan Research | Consumers, business professionals, and healthcare stakeholders | Daily updates on recruitment status and quality checks | Not stated on pages reviewed | Not published | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| IQVIA Australia | – | – | – | ● | – | – |
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| Ipsos Australia | ● | ● | – | ● | ● | ● |
| M3 Global Research | ● | ● | ● | ● | ● | ● |
| Kantar Australia | ● | – | – | ● | – | – |
| Sago | ● | ● | ● | ● | – | ● |
| Ruby Cha Cha | ● | ● | – | ● | – | – |
| Hummingbird Insight | ● | ● | – | ● | – | – |
| Lonergan Research | ● | ● | ● | ● | – | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Score providers based on their demonstrated ability to deliver clinical precision, data security, and strategic clarity within the Australian regulatory environment.
| Criterion | Weight | What it means here |
|---|---|---|
| Industry Expertise | 20 | This measures the depth of knowledge regarding the Australian healthcare system, therapy areas, and clinical workflows. High scores reflect a firm's ability to work through PBS dynamics and physician behaviors. Good performance requires not just research skills, but a demonstrable track record in translating medical complexity into strategic business value for clients. |
| Compliance, Certifications and Security | 20 | This assesses adherence to international standards like ISO 20252, ISO 27001, and HIPAA, plus local privacy laws. It covers data protection, consent management, and adverse event reporting procedures. High scores are awarded to firms that maintain rigorous, audited security frameworks to protect sensitive health data and maintain professional integrity throughout every study. |
| Target Audience Reach | 15 | This evaluates the ability to access specific, often hard-to-reach healthcare professionals and patients. It requires verified, proprietary panels rather than rented lists. High scores go to agencies that offer granular profiling, low-incidence targeting, and clear feasibility reporting to protect the sample accurately represents the target population for the study. |
| Research Quality | 10 | This focuses on the rigor of study design, sampling techniques, and data validation. It includes mechanisms for detecting fraud, speeding, and straight-lining. Good performance is evidenced by transparent quality controls and a commitment to delivering reliable, actionable data that holds up to internal scrutiny and supports high-stakes decision-making. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This examines the range of tools available, from traditional CATI and surveys to advanced techniques like ethnography, online communities, and behavioral science. High scores indicate a capability to match the method to the specific business question, making sure that both the 'what' and 'why' of respondent behavior are captured effectively. |
| Analytical Capability | 5 | This measures the firm's capacity to synthesize raw data into clear, strategic recommendations. It assesses the ability to segment audiences, identify market tensions, and provide actionable insights. High-scoring firms act as strategic partners, not just data suppliers, helping clients solve complex problems with evidence-based, creative, and professional advice. |
| Client Service and Speed | 5 | This evaluates responsiveness, project management, and the ability to turn around studies within tight timelines. High scores reflect a culture of proactive communication, clear project updates, and the ability to resolve fieldwork challenges without compromising quality. It reflects a partner's commitment to meeting the client's commercial objectives reliably. |
| Pricing and Feasibility Transparency | 5 | This assesses the honesty and clarity of feasibility assessments, incidence rates, and project costs. High scores are given to providers that provide realistic, evidence-based projections at the outset, avoiding surprises during fieldwork. It is a fundamental indicator of a trusted, long-term relationship between the agency and the research buyer. |
Why these weights. Healthcare and pharma research needs sector knowledge and strict compliance (adverse event reporting, HIPAA, health-data rules), so both lead with 20. Access to physicians, patients and payers follows (15), then design rigour and methods (10 each); analysis, service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: market research companies in Australia
IQVIA Australia: best for end-to-end clinical and commercial data analytics

Strongest fitLarge pharmaceutical companies managing complex clinical trials and commercial launches.
IQVIA combines proprietary data assets with advanced technology to support life sciences organizations. Its Australian operations offer expertise in real-world evidence, clinical trial management, and commercial execution, aiming to accelerate innovation and improve patient outcomes.
The firm provides a connected intelligence approach, integrating clinical and commercial services. It supports partners through data-driven strategies, using its extensive global footprint and specialized teams to address complex pharmaceutical challenges.
Scorecard: 88.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 88.0 |
Core services
- Clinical Development: Full-service clinical trials and biotech-focused development solutions.
- Commercial Analytics: Data-driven insights to optimize field force performance and market opportunity assessment.
- Real-World Evidence: Generation of evidence to support market access and asset value maximization.
Strengths
- Data Assets: Access to petabytes of proprietary data and non-identified patient records.
- Technological Integration: Unified platforms and agentic AI to predict market and clinical outcomes.
- Functional Outsourcing: Flexible FSP models for managing clinical trial operations and regulatory documentation.
Innovation and technology
- IQVIA.ai Platform: A unified agentic platform for commercial and clinical decision-making.
- Predictive Models: Life science models designed to forecast clinical and commercial success.
Impact on businesses
- Efficiency Gains: Optimized clinical trials and commercial execution to reduce costs and time to market.
- Strategic Foresight: Informed decision-making through the connection of data, technology, and expertise.
Why it may fit your brief
It excels in data-heavy clinical and commercial projects. Smaller firms looking for qualitative, boutique-style brand research may find a smaller, more specialized agency to be a better fit.
Global Vox Populi: best for large-scale international healthcare professional research
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant

Strongest fitGlobal healthcare brands requiring verified, high-quality data for multi-market projects.
Global Vox Populi provides primary market research services supported by its own proprietary panels. In Australia, the company maintains a significant presence with healthcare professionals, patients, and nurses and allied health professionals, protecting solid data collection for complex studies.
The agency acts as a full-service partner, managing projects from design to analysis. Its focus on healthcare market research in Australia is underpinned by rigorous quality controls, including rolling re-validation of panel members and compliance with international data protection standards.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in Australia
23,864 panellists
- Primary & General8,138
- Internal Medicine Subspecialties2,810
- Surgical Specialties2,132
- Diagnostic & Laboratory1,860
- Acute, Peri-operative & Critical Care1,622
- Women's & Reproductive Health1,506
Patient panel, in Australia
772,736 patient profiles
- Aesthetics & Cosmetic252,023
- Cardiovascular55,536
- Ophthalmology42,531
- Endocrinology & Metabolic41,149
- Dermatology38,806
- Women's Health37,368
Across 731 conditions; a patient with more than one condition is counted once per condition.
Nurses and allied health panel, in Australia
47,451 panellists
- Registered Nurses15,864
- Advanced Practice Nurses3,204
- Licensed / Practical / Enrolled Nurses3,185
- Nursing Support (Aides / HCAs)1,543
- Midwives1,096
- Pharmacists & Pharmacy Techs3,418
Scorecard: 85.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 10/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Research Quality | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Analytical Capability | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 85.5 |
Core services
- Healthcare Professional Panels: Access to 23,864 Australian professionals, including primary care, specialists, and laboratory staff.
- Patient and Caregiver Research: Proprietary access to 772,736 patient profiles across therapeutic areas like cardiovascular and ophthalmology.
- Full-Service Methodology: End-to-end management of qualitative and quantitative studies, including focus groups and online surveys.
Strengths
- Panel Depth: Proprietary access to healthcare professionals and patients protects high-quality, verified data.
- Data Integrity: Rigorous fraud detection and identification fingerprinting protect reliable, clean data delivery.
- Global Standards: ISO 9001, 20252, and 27001 certifications provide a foundation for secure, compliant research operations.
Innovation and technology
- Proprietary Platform: Internal programming and hosting tools allow for custom survey design and real-time data management.
- Digital Engagement: Advanced mobile and WhatsApp-assisted survey tools to reach respondents in their preferred environments.
Impact on businesses
- Strategic Decision Support: Actionable insights that guide product launches, commercialization, and patient-centric strategy development.
- Regulatory Compliance: Adverse event reporting and HIPAA compliance support safe and ethical data handling.
Why it may fit your brief
It is ideal for briefs requiring deep access to niche medical audiences and strict data security. Firms seeking purely localized, small-scale PR research might consider boutique agencies instead.
Ipsos Australia: best for public health and patient experience tracking

Strongest fitGovernment agencies and pharmaceutical firms tracking large-scale patient or public attitudes.
Ipsos delivers research on society, markets, and people, with a dedicated health service practice. In Australia, it tracks perceptions of healthcare quality and public health issues, helping organizations work through patient needs and regulatory environments.
The agency uses a range of methodologies, including surveys, polls, and qualitative research, to provide actionable truths. Its approach is built on curiosity and a partnership-focused model, supporting clients in making confident, evidence-based decisions.
Scorecard: 82.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 82.0 |
Core services
- Health Service Research: Tracking perceptions of healthcare systems, quality of care, and public health issues.
- Patient and Doctor Insights: Research into the experiences, opinions, and attitudes of patients and healthcare professionals.
- Brand and Strategy: Market strategy, brand health tracking, and understanding of market dynamics.
Strengths
- Global Trends: Extensive experience in tracking global public opinion and health service perceptions.
- Methodological Range: Capability to use surveys, social media analysis, and qualitative research.
- Strategic Partnership: Focus on long-term relationships and deep business understanding.
Innovation and technology
- AI Insights: Integration of AI to deliver faster and more consistent insights across markets.
- Online Communities: Use of proprietary panels and digital communities for ongoing consumer engagement.
Impact on businesses
- Better Decision Making: Providing reliable information to help organizations act faster and more confidently.
- Market Understanding: Delivering true understanding of societal and patient-driven trends.
Why it may fit your brief
It is well-suited for tracking public opinion and broad patient sentiment. For highly specific clinical or physician-led technical research, specialized medical panels may offer faster results.
M3 Global Research: best for rapid physician and specialist recruitment

Strongest fitAgencies and pharmaceutical companies requiring fast access to hard-to-reach medical specialists.
M3 Global Research focuses on recruitment and data collection for the healthcare industry. It manages a large, verified panel of healthcare professionals worldwide, including GPs, specialists, nurses, and pharmacists in Australia.
The company supports market research agencies and pharmaceutical clients by providing rapid access to medical insights. Its services are designed to support high-quality quantitative and qualitative fieldwork, making sure that clients can reach difficult-to-find medical audiences.
Scorecard: 80.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 10/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 5/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 6/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 80.0 |
Core services
- Fieldwork Services: Recruitment and data collection for medical market research studies.
- HCP Panel Access: Access to a verified, global panel of physicians and allied health professionals.
- Support Services: Project support for both quantitative and qualitative healthcare studies.
Strengths
- Verified Panel: Panel of over 2 million verified physicians and healthcare professionals.
- Global Reach: Operations covering 248 markets across 70 countries.
- Healthcare Focus: Strong specialization in the medical space, with deep experience in physician engagement.
Innovation and technology
- Digital Panel Management: Efficient recruitment tools for rapid access to specialized medical professionals.
Impact on businesses
- Rapid Insights: Faster access to medical experts to inform product and clinical decisions.
- High-Quality Data: Reliable responses from verified practitioners for clinical and marketing studies.
Why it may fit your brief
It is ideal for rapid fieldwork and data collection among medical professionals. Firms needing broader, full-service strategic consulting or patient-journey deep dives might prefer a different partner.
Kantar Australia: best for brand growth and creative effectiveness testing

Strongest fitConsumer health brands seeking to optimize marketing spend and improve brand positioning.
Kantar provides marketing intelligence, focusing on brand strategy and creative effectiveness. Its Australian team works with healthcare brands to understand how consumers perceive their products and how to optimize marketing investments for better commercial impact.
The company emphasizes the use of its proprietary Intelligence Engine, which combines human and synthetic data with AI to provide predictive evidence. This approach helps brands work through fast-changing markets while maintaining human understanding.
Scorecard: 78.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | kantaraustralia.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | kantaraustralia.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | kantaraustralia.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | kantaraustralia.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | kantaraustralia.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | kantaraustralia.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | kantaraustralia.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | kantaraustralia.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 78.5 |
Core services
- Brand Strategy: Tools for measuring brand value and developing growth strategies rooted in consumer behavior.
- Creative Effectiveness: Frameworks such as the LINK suite to assess content impact and engagement.
- Market Analytics: Predictive analytics to link marketing actions to enterprise value.
Strengths
- Intelligence Engine: Combines human data, synthetic data, and AI-native platforms.
- Commercial Focus: Strong emphasis on proving the ROI of marketing and brand investment.
- Methodological Rigor: Validated methodologies for measuring brand impact and cultural resonance.
Innovation and technology
- AI Integration: Using AI to amplify human judgment in processing large volumes of market signals.
- Creator Effectiveness Framework: Tools specifically designed to measure the impact of influencer and creator content.
Impact on businesses
- Strategic Growth: Guidance on building sustainable brand value in competitive sectors.
- Optimized Marketing: Improved marketing efficiency by aligning content with proven drivers of brand impact.
Why it may fit your brief
It is highly effective for consumer-facing healthcare marketing and media strategy. Agencies focusing on physician-specific clinical or regulatory research may provide more relevant expertise for technical medical products.
Sago: best for agile quantitative and qualitative data collection

Strongest fitCompanies needing agile, self-serve quantitative tools and flexible qualitative research facilities.
Sago provides end-to-end research solutions, including digital qualitative and quantitative tools. In Australia, it supports healthcare research through participant recruitment and flexible facility access for focus groups and interviews.
The company emphasizes agility, helping clients connect with hard-to-reach respondents through its global network. Its consultative approach assists clients in selecting the best methodologies for their specific study needs, supported by advanced research technologies.
Scorecard: 76.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 4/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | sago.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | sago.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 76.5 |
Core services
- Digital Research Solutions: Online tools for qualitative and quantitative research, including survey programming.
- Participant Recruitment: Access to diverse healthcare audiences for studies of all types.
- Consultative Support: Expert advice on methodology selection and project execution.
Strengths
- Global Reach: Large-scale respondent network with 176 million people surveyed.
- Flexible Facilities: Physical and digital spaces for honest feedback and deeper insight.
- Data Quality Pledge: Commitment to research data quality through initiatives like SagoVerify.
Innovation and technology
- Methodify Platform: A self-serve, DIY quantitative research platform for faster insights.
- AI-Powered Tools: Tools like Query AI and video summaries to accelerate data interpretation.
Impact on businesses
- Agile Decision Making: Reducing timelines and costs for creative and concept testing.
- Audience Engagement: Better understanding of customer behavior through accessible, deep insights.
Why it may fit your brief
It is highly effective for fast-turnaround quantitative projects and focus group logistics. For highly specialized regulatory or scientific healthcare consulting, a firm with deeper clinical expertise may be required.
Ruby Cha Cha: best for deep qualitative insights and ethnographic research

Strongest fitHealthcare brands needing deep qualitative insights to understand patient and practitioner motivations.
Ruby Cha Cha acts as a strategic partner to healthcare and biotechnology organizations, focusing on qualitative research to reveal the ‘why’ behind behaviors. It combines deep market expertise with creative methodologies to help clients work through the competitive healthcare environment.
The agency emphasizes collaboration, working as an extension of the client’s team. Its approach is built on uncovering emotional drivers and tensions, providing insights that go beyond standard data collection to inform targeted strategies.
Scorecard: 71.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | rubychacha.com.au (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | rubychacha.com.au (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | rubychacha.com.au (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | rubychacha.com.au (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | rubychacha.com.au (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | rubychacha.com.au (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | rubychacha.com.au (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | rubychacha.com.au (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 71.0 |
Core services
- Qualitative Research: Focus groups, in-depth interviews, and ethnography to uncover underlying motivations.
- Strategic Consulting: Reframing complex problems into actionable, innovative solutions.
- Customer Journey Mapping: Analysis of behavioral experiences to improve brand interaction.
Strengths
- Deep Expertise: Specialized knowledge in decoding market shifts and consumer behavior.
- Creative Approach: Blending qualitative and quantitative techniques to humanize data.
- Collaborative Partnership: Deep integration with client teams to protect alignment and shared success.
Innovation and technology
- Online Communities: Supporting focus groups to encourage debate and uncover real tensions.
Impact on businesses
- Strategic Growth: Helping businesses turn challenges into opportunities through fresh perspectives.
- Deeper Connections: Enabling brands to craft strategies that spark deeper connections with audiences.
Why it may fit your brief
It is perfect for exploratory, qualitative research projects. For high-volume quantitative studies or international clinical data collection, a larger agency with specialized panels might be more appropriate.
Hummingbird Insight: best for behavioral science-led healthcare strategy

Strongest fitPharmaceutical brands seeking a behavioral science approach to marketing strategy.
Hummingbird Insight focuses on healthcare, pharmaceutical, and medical market research, challenging assumptions to develop effective strategies. It uses a blend of behavioral science and research expertise to help clients solve commercial and marketing challenges.
The agency emphasizes ‘insights-enabled activation,’ providing clear stories and realistic recommendations. Its team, which includes psychologists and researchers, works to understand the decision-making processes of healthcare professionals and patients.
Scorecard: 70.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | hummingbirdinsight.com.au (1 page reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | hummingbirdinsight.com.au (1 page reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | hummingbirdinsight.com.au (1 page reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | hummingbirdinsight.com.au (1 page reviewed), Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | hummingbirdinsight.com.au (1 page reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | hummingbirdinsight.com.au (1 page reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | hummingbirdinsight.com.au (1 page reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | hummingbirdinsight.com.au (1 page reviewed), Oct 2026 |
| Weighted score | 100 | 70.5 |
Core services
- Behavioral Science: Applying psychological principles to understand decision-making in healthcare.
- Strategic Consulting: Delivering clear, actionable guidance to move brands toward their potential.
- Integrated Research: Cohesive storytelling combining qualitative and quantitative streams.
Strengths
- Behavioral Expertise: Application of psychology to gain deeper insights into health populations.
- Clear Communication: Focus on storytelling to drive home key messages for brand teams.
- Strategic Activation: Translating research into actionable tactics rather than static reporting.
Innovation and technology
- Dualist Research: Integrated approach where qual and quant are treated as a cohesive story.
Impact on businesses
- Performance Recovery: Helping brands regain performance and launch programs optimally.
- Clarity of Thought: Providing clear answers to complex challenges faced by health brand teams.
Why it may fit your brief
It is an ideal choice for brands needing to understand the 'why' behind clinical behavior. For high-volume data collection or large-scale global trials, a larger agency with specialized panels may be more effective.
Lonergan Research: best for tailored B2B and B2C research strategy

Strongest fitOrganizations requiring custom, strategic research with a strong focus on local Australian market context.
Lonergan Research provides tailored market research solutions to commercial and government clients. It combines various disciplines, including ethnography and big data, to address complex business challenges in the Australian market.
The agency acts as a strategic partner, focusing on providing actionable insights rather than just raw data. It manages its own in-house field service team, protecting flexibility and quality control across its research projects.
Scorecard: 68.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | lonerganresearch.com.au (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | lonerganresearch.com.au (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | lonerganresearch.com.au (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | lonerganresearch.com.au (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | lonerganresearch.com.au (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | lonerganresearch.com.au (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | lonerganresearch.com.au (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | lonerganresearch.com.au (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 68.0 |
Core services
- Strategic Consulting: Evidence-based insights to drive strategic business decisions.
- Field Services: End-to-end management of qualitative and quantitative fieldwork across Australia.
- PR and Communications: Research-led insights to support media and PR activities.
Strengths
- In-House Fieldwork: Direct control over recruitment and data collection, including focus group rooms.
- Methodological Neutrality: Use of the best tools to meet specific research needs without bias.
- Hard-to-Reach Recruitment: Track record in recruiting respondents with very low incidence levels.
Innovation and technology
- Content Research: Integration of research with PR and communication strategies to amplify impact.
Impact on businesses
- Strategic Clarity: Delivering evidence-based insights that shape corporate and clinical strategies.
- Customer Experience: Improved business outcomes through better understanding of customer needs.
Why it may fit your brief
It is an excellent partner for bespoke, strategically focused projects. For large-scale international clinical studies, agencies with dedicated global medical panels may offer better scalability.
How HCP and patient verification actually works in Australia
Verify respondent authenticity through documented, rolling re-validation processes and identity-fingerprinting technology.
Professional Credential Checking
For healthcare professionals, firms must verify current medical registration or license numbers against official registries. Always request evidence of how the agency updates these records to make sure participants remain active practitioners. A lack of periodic re-validation can lead to lists of inactive or retired doctors, compromising your data quality.
Identity and Device Fingerprinting
Reliable providers use technical checks to confirm each respondent is a unique individual. This includes device ID fingerprinting, geo-location tracking, and VPN detection to prevent multiple survey completions from the same person or location. Ask for a summary of their digital security measures during the setup phase.
Behavioral Fraud Detection
Look for agencies that use trap questions, straight-lining detection, and minimum time-to-complete thresholds. These methods catch bots and inattentive respondents who might skew your results. A solid process will automatically flag or remove poor-quality completes before the data is delivered to your analysis team.
Consent and Compliance Audit
Make sure that the agency follows strict double opt-in procedures and provides clear, granular consent for data usage. In the Australian market, this includes alignment with local privacy regulations. Ask the provider to share their process for handling participant withdrawal and their adherence to international codes such as the ICC/ESOMAR Code.
How to choose the right provider in Australia
Select a partner by mapping their core methodology to your specific research objective, whether it is high-volume data or deep clinical strategy.
- Define Research Objective: Determine if your project requires broad quantitative data or deep qualitative understanding. Choose between large agencies for scale or boutique firms for specialized consulting.
- Assess Audience Access: Evaluate the agency's ability to reach your specific medical audience. Check if they own their proprietary panels or if they rely on external, rented lists.
- Review Compliance Standards: Prioritize firms with verified certifications like ISO 20252 and HIPAA. Protect they demonstrate a clear process for handling sensitive healthcare data and adverse event reporting.
- Evaluate Analytical Depth: Look for firms that provide strategic recommendations over mere data tables. The best partners act as extensions of your team, not just data suppliers.
- Request Feasibility Proof: Ask for transparent evidence of the sample size and incidence rate for your target group. Avoid agencies that provide vague responses about their ability to recruit.
Questions to ask before you commission
- How do you verify the medical credentials of your healthcare professional panelists, and how often is this data re-validated?
- Can you provide a clear breakdown of your feasibility for this specific audience, including incidence rates and recruitment timelines?
- What specific methodologies do you use to protect data quality and detect fraudulent completes or bots in your surveys?
- How do you handle adverse event reporting to protect compliance with local and international pharmaceutical regulations?
- Can you share examples of how your research has directly influenced strategic decision-making for similar healthcare clients?
- What security protocols do you have in place for protecting sensitive health data, and are you certified to international standards?
Common pitfalls to avoid
- Over-reliance on Rented Lists: Using agencies that rent panels rather than owning them often leads to inconsistent data quality and lower response rates.
- Ignoring Regulatory Nuance: Failing to account for the Australian PBS and local clinical guidelines can result in insights that are not applicable to the market.
- Focusing Only on Price: Selecting the cheapest provider often results in poor participant recruitment or lack of analytical rigor in the final report.
- Lack of Data Validation: Neglecting to check for fraud detection and respondent quality at the start of a project can jeopardize the entire study.
What a feasibility check should include
A reliable feasibility check must provide realistic incidence rate estimates and confirm access to verified medical audiences before the project commences.
Incidence Rate Analysis
The provider must accurately estimate the percentage of the target population that qualifies for your study. Inaccurate estimates lead to project delays and budget overruns.
Sample Feasibility Proof
Request a count of your specific audience within their panel. If they cannot provide this, it is likely they do not have direct access and will need to outsource recruitment.
Recruitment Timeline
Make sure the agency provides a clear, realistic schedule for fieldwork based on their current panel availability. Avoid providers who promise unrealistic turnaround times without evidence.
Audience Granularity
Verify the provider can filter by the specific sub-specialties or patient conditions you need. Generic panels often fail to deliver the precision required for clinical studies.
Conclusion
Choosing the right partner from the list of healthcare market research companies in Australia depends on the scope and technical nature of your project. For large-scale studies requiring verified professional access across multiple therapeutic areas, Global Vox Populi offers the necessary proprietary infrastructure. If your priority is consumer-facing marketing or creative testing, agencies like Kantar Australia provide excellent brand-focused capabilities, whereas specialists like M3 Global Research excel in rapid physician recruitment.
Use the provided scorecard as a baseline to evaluate potential firms against your project’s specific needs. Prioritize partners that demonstrate both deep clinical insight and rigorous adherence to data security standards. Ultimately, the best agency is one that functions as a strategic partner, delivering reliable evidence to drive your brand’s growth and patient outcomes in the 2026 healthcare market.
Planning research in Australia? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
What are the top healthcare market research companies in Australia?
The top companies include Global Vox Populi for full-service international research, IQVIA for clinical and commercial analytics, Kantar for brand strategy, Ipsos for public health tracking, M3 Global Research for physician recruitment, Sago for agile data collection, Lonergan Research for bespoke strategic consulting, and Hummingbird Insight for behavioral-led research.
How do I choose a healthcare market research agency in Australia?
Choose based on your specific needs: prioritize firms with proprietary, verified panels for clinical research, and agencies with strong analytical capabilities for brand strategy. Always verify their ISO certifications and demand evidence of their recruitment process to protect the accuracy of your research data.
What is the role of market research in the Australian pharmaceutical industry?
Market research supports pharmaceutical companies by providing data on physician attitudes, patient journeys, and market access. It is used to inform product launches, optimize marketing strategies, and work through the regulatory environment, including the influence of the PBS on product uptake and patient affordability.
Are there specialized healthcare research panels in Australia?
Yes, several agencies maintain specialized healthcare panels. For example, Global Vox Populi, M3 Global Research, and other established firms offer access to verified lists of physicians, nurses, and patients, which are essential for conducting rigorous and reliable healthcare research.
How does the PBS influence healthcare market research in Australia?
The Pharmaceutical Benefits Scheme (PBS) is a critical factor in Australian healthcare. Research often focuses on understanding how PBS listing status affects physician prescribing behavior, patient access, and overall brand competitiveness within the local market.
What methodologies are most effective for HCP research in Australia?
Effective methodologies include quantitative surveys for broad sentiment tracking, and qualitative methods like in-depth interviews and focus groups for uncovering the 'why' behind clinical decisions. Ethnography is also valuable for understanding real-world patient and practitioner behaviors in clinical settings.
How much does healthcare market research cost in Australia?
Costs vary significantly based on project complexity, target audience rarity, and methodology. A simple survey may have a lower cost than a multi-stage qualitative project involving hard-to-reach specialists. Most agencies provide project-based quotes after a detailed feasibility assessment.
What is the difference between generalist and specialist healthcare agencies?
Specialist agencies focus exclusively on the medical sector, offering deep clinical expertise and dedicated panels. Generalist agencies may have a health practice but often bring broader marketing and consumer research experience, which can be useful for consumer-facing health brands or cross-industry insights.